Metabolic characteristics of women who developed ovarian hyperstimulation syndrome

Human Reproduction

Volumn 17, Issue 8, 2002, Pages 1994-1996

  Delvigne, Annick ^a   Kostyla, Karol ^a   De Leener, Anne ^b   Lejeune, Bernard ^c   Cantiniaux, Brigitte ^a   Bergmann, Pierre ^d   Rozenberg, Serge ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c Institut Medical Edith Cavell   (Belgium)

^d BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Insulin resistance; IVF; Ovarian hyperstimulation syndrome (OHSS)

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROTEIN C; PROTEIN S; PROTHROMBIN; RECOMBINANT FOLLITROPIN; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CALCULATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE MUTATION; GENETIC POLYMORPHISM; HEMOSTASIS; HOMEOSTASIS; HUMAN; HYPERINSULINISM; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MORBIDITY; OUTCOMES RESEARCH; OVARY HYPERSTIMULATION; OVULATION INDUCTION; POPULATION RESEARCH; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOEMBOLISM; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; METABOLISM; MUTATION; PATHOPHYSIOLOGY; RISK FACTOR; THROMBOSIS;

FALLOPIA;

ADULT; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERINSULINISM; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OVARIAN HYPERSTIMULATION SYNDROME; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOSIS;

EID: 0035988485     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.8.1994     Document Type: Article

References (20)

1. Postnatal screening for thrombophilia in women with severe pregnancy complications
2. The role of hyperinsolinemia in the pathogenesis of ovarian hyperandrogenism
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
5. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
6. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome
7. Clinical assessment of body hair growth in women
8. A candidate genetic risk factor for vascular disease: A common mutation in methylene tetrahydrofolate reductase
9. The impact of insulin secretion on the ovarian response to exogenous gonadotrophins in polycystic ovary syndrome
10. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in-vitro fertilized embryos, and miscarriage
11. Ovarian hyperstimulation syndrome: An update review
12. Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes
13. Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation
14. Science, medicine, and the future: Assessing thrombotic risk
15. The importance of diagnosing the polycystic ovary syndrome
16. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
17. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins
18. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
19. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures
20. Clinical aspects of ovarian hyperstimulation syndrome